Last edition
News about "Korea Disease Control and Prevention Agency"
GC Biopharma Wins IND Approval in Korea for Phase I COVID-19 mRNA Vaccine Trial
GC Biopharma has received IND approval in Korea to initiate a Phase I clinical trial of its COVID-19 mRNA vaccine, marking a key step in advancing its mRNA platform, with plans to submit a Phase II IND in the second half of 2026.
Korea Disease Control And Prevention Agency | 24/12/2025 | By News Bureau | 135
Korean Ministry Grants Approval to GC Biopharma's BARYTHRAX Anthrax Vaccine
With the approval by MFDS, BARYTHRAX has become Korea's 39th novel drug.
Korea Disease Control And Prevention Agency | 09/04/2025 | By Abha | 212
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy